RCT to Investigate if Prophylactic Antibiotics Prevent Further Episodes of Cellulitis (Erysipelas) of the Leg

PHASE4CompletedINTERVENTIONAL
Enrollment

274

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Cellulitis/Erysipelas of the Leg
Interventions
DRUG

Penicillin VK

Biconcave tablet 250mg oral, b.d.

OTHER

placebo

biconcave tablet matching active comparator as much as possible in size and shape

Trial Locations (25)

Unknown

South Infirmary-Victoria University Hospital, Cork

NG7 2UH

Queens Medical Centre, Nottingham

AB25 2ZN

Aberdeen Royal Infirmary, Aberdeen

HP7 0JD

Amersham Hospital, Amersham

BN2 3EW

Brighton General Hospital, Brighton

BS2 8HW

Bristol Royal Infirmary, Bristol

CA2 7HY

Cumberland Infirmary, Carlisle

DE1 2QY

Derbyshire Royal Infirmary, Derby

DE1 5TW

University Hospital of North Durham, Durham

GL1 3NN

Gloucestershire Royal Infirmary, Gloucester

NR31 6LA

James Paget University Hospital, Great Yarmouth

HU8 9HE

Princess Royal Hospital, Hull

IP4 5HD

Ipswich Hospital, Ipswich

PE30 4ET

Queen Elizabeth Hospital, Kings Lynn

LE1 5WW

Leicester Royal Infirmary, Leicester

L14 3LB

Broadgreen Hospital, Liverpool

BT47 6SB

Altnagelvin Area Hospital, Londonderry

NE1 4LP

Royal Victoria Infirmary, Newcastle upon Tyne

NR4 7UY

Norfolk and Norwich University Hospital, Norwich

RG1 5AN

Royal Berkshire Hospital, Reading

M6 8HD

Hope Hospital, Salford

NG17 4JL

King's Mill Hospital, Sutton in Ashfield

SA2 8QA

Singleton Hospital, Swansea

WD1 8HB

Watford General Hospital, Watford

YO31 8HR

York Hospital, York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Action Medical Research

OTHER

collaborator

UK Dermatology Clinical Trials Network

NETWORK

lead

University of Nottingham

OTHER

NCT00552799 - RCT to Investigate if Prophylactic Antibiotics Prevent Further Episodes of Cellulitis (Erysipelas) of the Leg | Biotech Hunter | Biotech Hunter